Connected care only matters if it reaches the clinic. In 2018 we partnered with Luz Saúde, a major Portuguese healthcare network, to put Respiro to work in asthma and COPD care, giving nursing teams a clearer view of how patients were doing between visits.
Respiro's inhaler sensors capture inhalation data to track how, and how often, medication is taken. The platform turns that into personalised medication reviews the care team can act on.
"Amiko has a great product that will completely change the way asthma and COPD patients and their health providers can improve the efficacy of the treatment."
Francisca Leite, Director of Hospital da Luz Learning Health
"For too long, respiratory care has run on guesswork between visits. Connected inhalers bring asthma and COPD into the digital age, where every dose is visible and every patient can be supported in time. Partnerships like this with Luz Saúde are how that future reaches real clinics."
Martijn Grinovero, Chief Commercial Officer, Amiko
Originally published 3 July 2018.